India’s Stem Cell Guidelines Mandate Additional Checks

Draft update to national guidelines factors in additional safeguards and makes it mandatory to establish institutional panels to review stem cell research. Gene editing would be an area of "restrictive" research.

CRISPR

Organizations working in India on stem cell research would be mandatorily required to establish an internal review committee specifically to focus on these projects and register it with a government oversight panel, under a proposed update to the country's draft National Guidelines for Stem Cell Research 2017.

The draft update builds on guidelines issued in 2013 and aims to encourage research with human stem cells while ensuring...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards